Documents

Report to monitor the European clinical trials environment (April-June 2026)

Update on Biotech Act and EU4Health Initiative

Update on MedEthicsEU

Survey insights on nuclear medicine clinical trials

MSP AG - group and mandate renewal

ACT EU workplan update 2026-2027

Meeting highlights MSP Advisory Group 20 March 2026

Report - ACT EU webinar on contractual agreements

Agenda MSP Advisory Group meeting 18 June 2026

Report to monitor the European clinical trials environment (January - March 2026)

ACT EU multi-annual workplan 2026-2027

Helpdesk for non-commercial sponsors: 15-month report

Executive summary of ACT EU matrix meeting 1 October 2025

Recommendations by the Coalition for Reducing Bureaucracy in Clinical Trials_R. Doeswijk (EHA)

eConsent initiative_H.Vanaken (EFGCP)

Framework for shared patient input in a specific indication across products_F.Houyez (EURORDIS)

Update on FAST-EU (Facilitating and Accelerating_M.Lunzer (CTCG , AGES)

Pre-CTA and SAWP-CTCG pilots_B.Garcia-Ochoa (EuropaBio)

EU model template for “Clinical site agreements” between sponsors and clinical sites_M.Matei (ECRIN)